1. Home
  2. ROIV vs KTOS Comparison

ROIV vs KTOS Comparison

Compare ROIV & KTOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$21.70

Market Cap

14.1B

Sector

Health Care

ML Signal

HOLD

Logo Kratos Defense & Security Solutions Inc.

KTOS

Kratos Defense & Security Solutions Inc.

HOLD

Current Price

$74.42

Market Cap

11.7B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROIV
KTOS
Founded
2014
1994
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Military/Government/Technical
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
14.1B
11.7B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
ROIV
KTOS
Price
$21.70
$74.42
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
14
Target Price
$21.94
$79.71
AVG Volume (30 Days)
6.7M
2.1M
Earning Date
11-10-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
27.23
EPS
N/A
0.13
Revenue
$20,329,000.00
$1,284,800,000.00
Revenue This Year
N/A
$19.25
Revenue Next Year
$376.94
$20.15
P/E Ratio
N/A
$600.94
Revenue Growth
N/A
14.00
52 Week Low
$8.73
$23.90
52 Week High
$22.45
$112.57

Technical Indicators

Market Signals
Indicator
ROIV
KTOS
Relative Strength Index (RSI) 62.44 46.12
Support Level $20.14 $73.20
Resistance Level $21.48 $79.47
Average True Range (ATR) 0.71 3.64
MACD 0.00 0.60
Stochastic Oscillator 65.96 47.89

Price Performance

Historical Comparison
ROIV
KTOS

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About KTOS Kratos Defense & Security Solutions Inc.

Kratos Defense & Security Solutions Inc develops and fields transformative, affordable technology, platforms, and systems. The company has two segments; The Kratos Government Solutions (KGS) segment is comprised of an aggregation of KGS operating segments, including its microwave electronic products, space, training, and cybersecurity, C5ISR/modular systems, turbine technologies, and defense and rocket support services operating segments and The Unmanned Systems segment consists of unmanned aerial, unmanned ground, unmanned seaborne and related command, control, and communications system businesses. The company derives a majority of its revenue from the Kratos Government Solutions segment.

Share on Social Networks: